SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis
NASDAQ:SMLR - Nasdaq - US81684M1045 - Common Stock - Currency: USD
Overall SMLR gets a fundamental rating of 6 out of 10. We evaluated SMLR against 190 industry peers in the Health Care Equipment & Supplies industry. SMLR gets an excellent profitability rating and is at the same time showing great financial health properties. SMLR has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a positive operating cash flow in the past year.
SMLR had positive earnings in 4 of the past 5 years.
Of the past 5 years SMLR 4 years had a positive operating cash flow.
1.2 Ratios
SMLR has a better Return On Assets (17.26%) than 96.28% of its industry peers.
The Return On Equity of SMLR (18.64%) is better than 93.62% of its industry peers.
SMLR has a Return On Invested Capital of 19.41%. This is amongst the best in the industry. SMLR outperforms 97.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SMLR is significantly above the industry average of 8.19%.
The last Return On Invested Capital (19.41%) for SMLR is well below the 3 year average (28.91%), which needs to be investigated, but indicates that SMLR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.26% | ||
| ROE | 18.64% | ||
| ROIC | 19.41% |
ROA(3y)27.74%
ROA(5y)41.22%
ROE(3y)30.74%
ROE(5y)50.92%
ROIC(3y)28.91%
ROIC(5y)39.78%
1.3 Margins
With an excellent Profit Margin value of 27.00%, SMLR belongs to the best of the industry, outperforming 96.28% of the companies in the same industry.
In the last couple of years the Profit Margin of SMLR has grown nicely.
The Operating Margin of SMLR (33.79%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
Looking at the Gross Margin, with a value of 88.05%, SMLR belongs to the top of the industry, outperforming 98.40% of the companies in the same industry.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.79% | ||
| PM (TTM) | 27% | ||
| GM | 88.05% |
OM growth 3Y-7.58%
OM growth 5Y5.61%
PM growth 3Y-5.96%
PM growth 5Y5.3%
GM growth 3Y-0.57%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SMLR has an Altman-Z score of 46.63. This indicates that SMLR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 46.63, SMLR belongs to the top of the industry, outperforming 98.94% of the companies in the same industry.
There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 46.63 |
ROIC/WACC2.12
WACC9.14%
2.3 Liquidity
A Current Ratio of 3.14 indicates that SMLR has no problem at all paying its short term obligations.
SMLR has a Current ratio (3.14) which is in line with its industry peers.
A Quick Ratio of 3.09 indicates that SMLR has no problem at all paying its short term obligations.
SMLR has a Quick ratio of 3.09. This is in the better half of the industry: SMLR outperforms 65.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.82%, which is quite impressive.
SMLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.17% yearly.
EPS 1Y (TTM)101.82%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%477.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.57%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-67.65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.60, which indicates a very decent valuation of SMLR.
97.34% of the companies in the same industry are more expensive than SMLR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SMLR to the average of the S&P500 Index (29.63), we can say SMLR is valued rather cheaply.
A Price/Forward Earnings ratio of 26.59 indicates a quite expensive valuation of SMLR.
Based on the Price/Forward Earnings ratio, SMLR is valued a bit cheaper than 75.00% of the companies in the same industry.
SMLR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 26.59 |
4.2 Price Multiples
75.00% of the companies in the same industry are more expensive than SMLR, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SMLR indicates a rather cheap valuation: SMLR is cheaper than 86.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.23 | ||
| EV/EBITDA | 23.49 |
4.3 Compensation for Growth
The excellent profitability rating of SMLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SMLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
47.74
-4.5 (-8.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners46.82%
Inst Owner Change35.23%
Ins Owners9.42%
Ins Owner Change4.56%
Market Cap458.30M
Analysts82.86
Price Target72.42 (51.7%)
Short Float %22.97%
Short Ratio3.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.41%
Min EPS beat(2)12.04%
Max EPS beat(2)90.78%
EPS beat(4)3
Avg EPS beat(4)19.64%
Min EPS beat(4)-25.76%
Max EPS beat(4)90.78%
EPS beat(8)7
Avg EPS beat(8)26.23%
EPS beat(12)9
Avg EPS beat(12)17.91%
EPS beat(16)12
Avg EPS beat(16)19.44%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.13%
Max Revenue beat(2)1.12%
Revenue beat(4)2
Avg Revenue beat(4)-6.09%
Min Revenue beat(4)-27.14%
Max Revenue beat(4)1.8%
Revenue beat(8)6
Avg Revenue beat(8)0.09%
Revenue beat(12)6
Avg Revenue beat(12)-2.22%
Revenue beat(16)9
Avg Revenue beat(16)-0.6%
PT rev (1m)77.5%
PT rev (3m)77.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)25.93%
EPS NY rev (3m)25.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)0.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 26.59 | ||
| P/S | 7.78 | ||
| P/FCF | 21.23 | ||
| P/OCF | 21.39 | ||
| P/B | 5.37 | ||
| P/tB | 21.96 | ||
| EV/EBITDA | 23.49 |
EPS(TTM)5.55
EY11.63%
EPS(NY)1.8
Fwd EY3.76%
FCF(TTM)2.25
FCFY4.71%
OCF(TTM)2.23
OCFY4.67%
SpS6.14
BVpS8.89
TBVpS2.17
PEG (NY)N/A
PEG (5Y)0.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.26% | ||
| ROE | 18.64% | ||
| ROCE | 23.33% | ||
| ROIC | 19.41% | ||
| ROICexc | 22.79% | ||
| ROICexgc | 201.87% | ||
| OM | 33.79% | ||
| PM (TTM) | 27% | ||
| GM | 88.05% | ||
| FCFM | 36.64% |
ROA(3y)27.74%
ROA(5y)41.22%
ROE(3y)30.74%
ROE(5y)50.92%
ROIC(3y)28.91%
ROIC(5y)39.78%
ROICexc(3y)143.15%
ROICexc(5y)152.24%
ROICexgc(3y)143.15%
ROICexgc(5y)152.24%
ROCE(3y)34.75%
ROCE(5y)47.82%
ROICexcg growth 3Y-8.52%
ROICexcg growth 5Y-23.37%
ROICexc growth 3Y-8.52%
ROICexc growth 5Y-23.37%
OM growth 3Y-7.58%
OM growth 5Y5.61%
PM growth 3Y-5.96%
PM growth 5Y5.3%
GM growth 3Y-0.57%
GM growth 5Y0.53%
F-Score4
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 26.45% | ||
| Cap/Sales | 0.29% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.24% | ||
| Profit Quality | 135.68% | ||
| Current Ratio | 3.14 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 46.63 |
F-Score4
WACC9.14%
ROIC/WACC2.12
Cap/Depr(3y)212.03%
Cap/Depr(5y)207.39%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.75%
Profit Quality(3y)98.27%
Profit Quality(5y)94.08%
High Growth Momentum
Growth
EPS 1Y (TTM)101.82%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%477.97%
EPS Next Y-67.65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.57%
Revenue Next Year1.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.76%
EBIT growth 3Y11.72%
EBIT growth 5Y33.04%
EBIT Next Year-13.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.4%
FCF growth 3Y12.63%
FCF growth 5Y39.65%
OCF growth 1Y23.05%
OCF growth 3Y12.18%
OCF growth 5Y35.33%